Introduction And Core Concept

  • Sustained Low-Efficiency Diafiltration (SLED), also referred to as prolonged intermittent renal replacement therapy (PIRRT), is a hybrid renal replacement therapy (RRT) for pediatric acute kidney injury (AKI).
  • It successfully combines the hemodynamic stability of continuous renal replacement therapy (CRRT) with the logistical simplicity and cost-effectiveness of intermittent hemodialysis (IHD).
  • SLED functions utilizing standard hemodialysis infrastructure but modifies parameters for safer pediatric application.

Operational Parameters

ParameterSLED SpecificationClinical Implication
Blood Flow Rate100–300 mL/min (100–200 mL/min specifically in children).Prevents rapid intravascular volume depletion.
Dialysate Flow Rate100–300 mL/min.Ensures slow, sustained solute clearance.
Session Duration6–12 hours daily.Avoids continuous 24-hour tethering to the machine.
AnticoagulationMinimal (frequently heparin-free or regional citrate).Reduces the severe bleeding risks associated with CRRT.

Rationale And Advantages In Pediatric Intensive Care

  • Pediatric AKI affects 20% to 30% of PICU admissions in India, primarily driven by sepsis, tropical infections, and dehydration.
  • Conventional IHD frequently triggers intradialytic hypotension in hemodynamically unstable children.
  • CRRT presents major resource barriers, requiring expensive machines, specialized consumables, and continuous highly trained nursing supervision.
  • SLED overcomes these barriers by utilizing lower ultrafiltration rates, providing slow fluid removal that prevents intradialytic hypotension (which occurs in only 10% to 20% of SLED sessions).
  • Extended session times achieve exceptional clearance of fluid and small-to-middle-molecular-weight solutes, including inflammatory cytokines.
  • Pediatric circuits are easily adapted for infants through adolescents utilizing age-adjusted flows and smaller tubing.
  • Operationally, SLED reduces overall RRT consumable costs by 30% to 50% compared to CRRT and allows for daytime execution by standard ICU nurses.

Clinical Application And Monitoring

  • Requires vigilant monitoring of effluent volume, intradialytic hypotension, and precise drug dosing.
  • Antimicrobial prescriptions must be carefully adjusted, as the prolonged 6-to-12-hour sessions can easily result in the under-dosing of critical antibiotics.
  • SLED provides excellent cytokine modulation in sepsis-associated AKI without inducing severe coagulation derangements.

Society Guidelines And Indian Integration

  • KDIGO 2026 Draft Guidelines: Formally acknowledges SLED/PIRRT as a highly viable hybrid alternative for hemodynamically unstable critically ill children when CRRT resources are limited.
  • IAP Guidelines (2025–2026 Endorsed): The Indian Academy of Pediatrics Standard Treatment Guidelines endorse SLED as a primary alternative to CRRT in unstable pediatric AKI, specifically recommending heparin-free protocols.
  • MoHFW And ICMR Workflows: Integrated into the 2025 Standard Treatment Workflows to expand cost-effective RRT access in public PICUs under Ayushman Bharat and the National Programme for Prevention and Control of Non-Communicable Diseases.

Future Directions

  • Ongoing clinical trials are actively exploring SLED-f (convective diafiltration) for enhanced middle-molecule clearance in septic shock.
  • SLED-VG (volume guarantee) protocols and AI-optimized prescriptions are emerging to further standardize pediatric fluid removal.